Schizoaffective Disorders Withdrawn Phase 3 Trials for Fenretinide (DB05076)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00534898Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia PatientsTreatment